Impact Biomedicines Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 4

Impact Biomedicines General Information

Description

Provider of biopharmaceutical therapies intended to treat hematologic malignancies and other serious diseases. The company develops targeted small-molecule therapies, including JAK2 kinase inhibitors, for the treatment of myelofibrosis, polycythemia vera, and related disorders, thereby helping patients access therapies for complex blood diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • 12526 High Bluff Drive
  • Suite 260
  • San Diego, CA 92130
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 12526 High Bluff Drive
  • Suite 260
  • San Diego, CA 92130
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Impact Biomedicines Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Impact Biomedicines‘s full profile, request access.

Request a free trial

Impact Biomedicines Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Impact Biomedicines‘s full profile, request access.

Request a free trial

Impact Biomedicines FAQs

  • When was Impact Biomedicines founded?

    Impact Biomedicines was founded in 2016.

  • Where is Impact Biomedicines headquartered?

    Impact Biomedicines is headquartered in San Diego, CA.

  • What industry is Impact Biomedicines in?

    Impact Biomedicines’s primary industry is Drug Discovery.

  • Is Impact Biomedicines a private or public company?

    Impact Biomedicines is a Private company.

  • What is Impact Biomedicines’s current revenue?

    The current revenue for Impact Biomedicines is .

  • How much funding has Impact Biomedicines raised over time?

    Impact Biomedicines has raised $112M.

  • Who are Impact Biomedicines’s investors?

    Medicxi Ventures (UK) and Sanofi have invested in Impact Biomedicines.

  • When was Impact Biomedicines acquired?

    Impact Biomedicines was acquired on 01-Jul-2026.

  • Who acquired Impact Biomedicines?

    Impact Biomedicines was acquired by Celgene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process